# the Safety, Tolerability, and Pharmacokinetics Study of HEC113995

> **NCT04623814** · PHASE1 · COMPLETED · sponsor: **Sunshine Lake Pharma Co., Ltd.** · enrollment: 58 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **OTHER:** Food
- **DRUG:** HEC113995
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT04623814
- **Lead sponsor:** Sunshine Lake Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-30
- **Primary completion:** 2020-08-12
- **Final completion:** 2020-08-12
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2020-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04623814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04623814, "the Safety, Tolerability, and Pharmacokinetics Study of HEC113995". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04623814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*